文献速递泌尿生殖MR

多参数MRI与临床因素预测≥3级前列腺癌

Predicting high-grade clinically significant prostate cancer.
PubMed 文献 · Abdom Radiol (NY) · 2026-01-12

该多中心回顾性研究纳入1245例PSA≥4 ng/mL且6个月内行前列腺活检或根治术的患者,利用多参数MRI结果与患者风险因素建立预测≥Grade Group 3临床有意义前列腺癌的logistic回归模型及计分系统。结果显示约28%患者累计得分0–7分,其预估风险为9%;模型和计分系统AUC均为0.77。

要点

  • 最高PI-RADS评分、前列腺外侵犯、PSA密度和年龄分组是预测≥Grade Group 3前列腺癌的显著因素。
  • 累计得分0–7分者约占28%,对应≥Grade Group 3前列腺癌预估风险为9%。
  • AUC为0.77,阅片时可将PI-RADS评分与PSA密度、年龄和前列腺外侵犯结合做风险分层。

核心结论

  • 年龄分组、PSA密度、多参数MRI最高PI-RADS评分和前列腺外侵犯可在logistic回归及计分系统中显著预测≥Grade Group 3临床有意义前列腺癌。
  • 该计分系统中约28%的患者累计得分为0–7分,对应≥Grade Group 3前列腺癌预估风险为9%。
  • logistic回归模型与计分系统的AUC均为0.77。

研究设计与样本

  • 经伦理委员会批准的回顾性队列研究,纳入2022年1月1日至12月31日多中心医疗系统中行前列腺多参数MRI的患者。
  • 纳入标准为PSA≥4 ng/mL且在MRI后6个月内接受前列腺活检和/或根治性前列腺切除术,共1245例患者。
  • 另设2015–2019年960例接受多参数MRI的男性作为独立推导队列。
  • 采用logistic回归和计分系统建模,预测因子包括PSA密度、多参数MRI最高PI-RADS评分、前列腺外侵犯和年龄分组。

关键影像表现/征象

  • 83%的患者存在PI-RADS评分≥3的局灶性病变。
  • 预测因子中的影像学指标包括多参数MRI最高PI-RADS评分和前列腺外侵犯。

诊断标准与关键数值

  • 预测目标为≥Grade Group 3临床有意义前列腺癌。
  • 约28%的患者累计得分为0–7分,对应≥Grade Group 3前列腺癌预估风险为9%。
  • logistic回归模型和计分系统的AUC均为0.77。
  • 纳入预测因子包括PSA密度、多参数MRI最高PI-RADS评分、前列腺外侵犯和年龄分组,例如65–<70岁。

临床应用与阅片要点

  • 在报告中可将PI-RADS最高评分与PSA密度、前列腺外侵犯和年龄信息联合用于≥Grade Group 3前列腺癌风险分层。
  • 累计得分0–7分患者的预估风险为9%,可帮助判断是否需要进一步穿刺或调整随访策略。

局限性

  • 研究为回顾性设计。
  • 研究人群中83%为白人,86%年龄≥60岁。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES:: To develop and validate a logistic regression model and point-based scoring system for predicting ≥Grade Group 3 clinically significant prostate cancer using a combination of multiparametric MRI findings and patient risk factors.

METHODS:: This Institutional Review Board-approved, retrospective cohort study was conducted1/1/2022–12/31/2022 with data analysis 7/1/2023–6/30/2025. Males undergoing prostate multiparametric MRI during the study period at a multi-institutional health system with prostate-specific antigen ≥4ng/mL and prostate biopsy and/or radical prostatectomy within 6 months post-multiparametric MRI were included in the study. A separate derivation cohort included 960 men who underwent multiparametric MRI from 2015–2019. A logistic regression and point-based scoring system for predicting high-grade clinically significant prostate cancer (≥Grade Group 3) was developed using predictors including prostate-specific antigen density (PSAD), highest PI-RADS score from multiparametric MRI, extraprostatic extension, and age groups (e.g., 65-<70). Discrimination was assessed using area under the curve.

RESULTS:: 1245 patients met inclusion criteria; 83% were White; 86% were ≥60 years of age. 83% had a focal lesion with PI-RADS score of ≥3. Based on the new point-based scoring system for predicting high-grade (≥Grade Group 3) prostate cancer, ~28% of patients had a cumulative score of 0–7, with an estimated clinically significant prostate cancer risk of 9%. The area under the curve was 0.77 for both the logistic regression model and the point-based system.

CONCLUSIONS:: In a multi-institutional health system, age, as well as prostate-specific antigen density, highest PI-RADS score from multiparametric MRI, and extraprostatic extension significantly predicted high-grade clinically significant prostate cancer in a logistic regression and point-based scoring system.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Lacson, Kikano, Haj-Mirzaian, et al. Predicting high-grade clinically significant prostate cancer. Abdom Radiol (NY). 2026. PMID: 41524984. doi:10.1007/s00261-025-05348-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。